India  

Zydus Lifesciences

Indian multinational pharmaceutical company

Zydus Lifesciences    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Zydus Lifesciences: Indian multinational pharmaceutical company
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacture of generic drugs. It ranked 100th in the Fortune India 500 list in 2020.

0
shares
ShareTweetSavePostSend
 

You Might Like


Zydus 2-dose Covid-19 vaccine gets regulatory nod


IndiaTimes - Published

DCGI grants approval to Corbevax for kids aged 5-12, Covaxin for 6-12 age group

The Drug Controller General of India (DCGI) on Tuesday granted emergency use approval to Covid-19 vaccines, Covaxin and Corbevax, for children below 12. Bharat Biotech's Covaxin has got nod for use in..
IndiaTimes - Published

2-shot Zydus vaccine may be rolled out soon

Soon a two-shot Covid-19 vaccine of Zydus LifeSciences could be rolled out, instead of the three-shot regimen currently approved. The company has received approval from the Subject Expert Committee..
IndiaTimes - Published

Covid-19: Two shot vaccine by Zydus gets SEC nod

Soon a two-shot Covid-19 vaccine of Zydus Cadila could be rolled out, instead of the three-shot regimen currently approved. The company has received approval from the Subject Expert Committee (SEC)..
IndiaTimes - Published

Zydus starts supply of its needle-free 3-dose vaccination to govt

Pharma major Zydus Cadila said on Wednesday it has started supplying its Covid-19 vaccine ZyCoV-D to the Centre, nearly six months after it had been authorised for emergency use in the 12 and above age..
IndiaTimes - Published

Zydus starts delivery of needless Covid-19 vaccines to central government

The company is also planning to make the vaccine available in the private market.
DNA - Published

Zydus Cadila's COVID-19 vaccine ZyCoV-D to be launched in THESE seven states initially

Zydus Cadila's COVID-19 vaccine ZyCoV-D will be introduced in seven Indian states in the first rollout, as per the health ministry.
DNA - Published

Zydus Cadila gets USFDA nod to market generic cancer drug in US


IndiaTimes - Published

Zydus Cadila's Covid vaccine to be administered only to adults as of now: Sources

Zydus Cadila's COVID-19 vaccine ZyCov-D, which has been cleared by India's drug regulator for those aged 12 years and above, will only be administered to adults as of now under the government's..
IndiaTimes - Published

Zydus Cadila to supply 1 crore doses of its 'needle-free' COVID-19 vaccine to govt at this price

The ZyCoV-D vaccine will be given through a needle-free applicator instead of a syringe.
DNA - Published

India to buy 10 million doses of Zydus Cadila's Covid-19 vaccine at about $4 each


IndiaTimes - Published

Zydus Cadila agrees to reduce its Covid vaccine price to Rs 265 a dose, final decision soon: Sources


IndiaTimes - Published

Procurement price of Zydus vax fixed, roll out soon: Govt


IndiaTimes - Published

Kids’ vaccine ZyCoV-D to be given to private hospitals too

The needle-free ZyCoV-D vaccine, manufactured by Zydus Cadila, has received emergency use authorisation for being administered to children between 12 and 17 years of age in India. The three-dose..
IndiaTimes - Published

Zydus Cadila proposes Rs 1900 for three-dose Covid vaccine; government negotiating to bring it down


IndiaTimes - Published

'Centre hopeful of positive outcome from final talks with Zydus Cadila for Covid vaccine for kids'

The Centre is hopeful of a positive outcome from the final round of discussions currently underway with Zydus Cadila for its Covid-19 vaccine for children, Karnataka Health Minister K Sudhakar said on..
IndiaTimes - Published

Covid: Zydus vaccine to be introduced in inoculation drive soon


IndiaTimes - Published

Centre likely to roll out 1 crore doses of Zydus Cadila's COVID-19 vaccine ZyCoVD by October - All you need to know

On PM Narendra Modi's 71st birthday, India set a new record for single-day vaccinations and administered over 2 crore COVID-19 vaccine doses.
DNA - Published

Zydus Cadila to seek approval for two-dose regimen of its approved three-dose Covid-19 vaccine in India


IndiaTimes - Published

Zydus Cadila's Covid-19 vaccine can be available from first week of October

The Union government is expecting Zydus Cadila's needle-free Covid-19 vaccine ZyCoV-D to be available from the first week of October. Further, a decision on whether all children or only those with..
IndiaTimes - Published

ZyCoV-D COVID vaccine likely to be available in market by mid to end September: MD Sharvil Patel

The ZyCoV-D COVID-19 vaccine, which received emergency use authorisation from India's drug regulator on Friday, will be available in the market by mid to end September, Zydus Group Managing Director..
DNA - Published

A momentous feat: PM Narendra Modi after Zydus Cadila's Covid vaccine gets emergency use authorisation

The department of biotechnology on Friday said indigenously developed Zydus Cadila Covid-19 vaccine ZyCoV-D has received approval for emergency use authorisation from the Drug Controller General of..
IndiaTimes - Published

Government approves first Covid-19 vaccine for children above 12 years

The company has indicated an initial visibility of supplying around 5 crore doses by December, a senior official said. While the government is yet to sign a final agreement with Cadila, supplies to the..
IndiaTimes - Published

Government panel recommends emergency use authorisation to Zydus Cadila's 3-dose Covid vaccine

The subject expert committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) deliberated on the application given by Zydus Cadila on Thursday and recommended granting..
IndiaTimes - Published

Covid vaccination for kids may start only by March ’22

Zydus Cadila's Covid-19 vaccine, ZyCoV-D, is expected to get an emergency use authorisation for the 12-18 cohort by end of August, whereas Bharat Biotech’s Covaxin – the world’s only vaccine..
IndiaTimes - Published